Global markets stabilize following the valuation-fueled tech rout, though the outlook for A.I. adoption remains mixed. In the U.S., the Supreme Court is hearing arguments over the legality of President Trump’s sweeping tariff agenda, with legal scholars split over the likely outcome. In the U.K., focus is back on the Bank of England ahead of today’s rate decision, with analysts split over the path forward given the recent spate of weaker data. It’s another busy day on the earnings front – Commerzbank reported a surprise fall in third quarter profit, though raised its revenue outlook with CEO Bettina Orlopp telling CNBC net interest income is improving. Meanwhile, the UK’s most valuable company, AstraZeneca, reported a strong set of results, beating on revenue and EPS while reiterating its full year guidance.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.